Keyphrases
Crude Extract
100%
Hepatitis C Virus
100%
Anti-hepatitis C Virus
100%
Longan
100%
Dimocarpus Longan Lour
100%
NS3/4A Protease
66%
Hepatitis C Virus Infection
33%
Antiviral Activity
33%
Anti-hepatitis C Virus Activity
33%
Hepatocellular Carcinoma
16%
Hepatitis C
16%
Hepatitis C Virus Genotypes
16%
JFH1
16%
Cytotoxicity
16%
Genotype 2a
16%
Time of Addition
16%
Adverse Effects
16%
Response Rate
16%
Effective Concentration
16%
Chronic Infection
16%
Co-treatment
16%
Cirrhosis
16%
Treatment Costs
16%
EC50
16%
Telaprevir
16%
Overall Cost
16%
Pegylated Interferon Plus Ribavirin
16%
Dimocarpus Longan
16%
Viral Entry
16%
Add-on Therapy
16%
Longan Leaves
16%
Cyclosporine
16%
Virion Assembly
16%
Virucidal
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hepacivirus
100%
Dimocarpus longan
100%
Hepatitis C Virus
57%
Proteinase Inhibitor
57%
Hepatitis C
42%
Infection
28%
Disease
14%
Antivirus Agent
14%
Cytotoxicity
14%
Liver Cell Carcinoma
14%
Adverse Event
14%
Antiviral Activity
14%
Liver Cirrhosis
14%
Immunosuppressive Agent
14%
Ribavirin
14%
EC50
14%
Telaprevir
14%
Peginterferon
14%
Ciclosporin
14%
Add on Therapy
14%
Immunology and Microbiology
Dimocarpus longan
100%
Hepacivirus
100%
Hepatitis C Virus
57%
Hepatitis C
42%
EC50
28%
Cytotoxicity
14%
Virion
14%
Immunosuppressive Drug
14%
Antiviral Activity
14%
Ciclosporin
14%
Pegylated Interferon
14%
Ribavirin
14%
Viral Entry
14%
Immunosuppressant
14%
Telaprevir
14%